Factor XI inhibitors show promise as a safer alternative to direct oral anticoagulants for preventing and treating thrombosis, offering similar efficacy with reduced bleeding risk.
Michelle Krey, PharmD Candidate
Advertisement
Articles by Michelle Krey, PharmD Candidate
Advertisement
Latest Updated Articles
Factor XI Inhibitors: The Future of AnticoagulationPublished: March 18th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
MFN, DTC, and the Policy Pressure Cooker: Reshaping the US Drug Market
3
FDA Approves Lumateperone With Antidepressant Use for Major Depressive Disorder
4
Population Genomic Screening Improves Lipid Management in Familial Hypercholesterolemia
5
